As of 2026-10-02, the Relative Valuation of Zentalis Pharmaceuticals Inc (ZNTL) is (37.47) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.60 USD, the upside of Zentalis Pharmaceuticals Inc based on Relative Valuation is -1538.5%.
The range of the Relative Valuation is (30.81) - (40.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 27.6x | 25.1x |
| Forward P/E multiples | 18.9x - 28.1x | 25.3x |
| Fair Price | (30.81) - (40.98) | (37.47) |
| Upside | -1282.8% - -1673.3% | -1538.5% |
| Date | P/E |
| 2026-09-25 | -1.82 |
| 2026-09-24 | -1.85 |
| 2026-09-23 | -1.93 |
| 2026-09-22 | -2.07 |
| 2026-09-21 | -2.04 |
| 2026-09-18 | -2.09 |
| 2026-09-17 | -2.07 |
| 2026-09-16 | -2.08 |
| 2026-09-15 | -2.10 |
| 2026-09-14 | -2.35 |
| 2026-09-11 | -2.36 |
| 2026-09-10 | -2.41 |
| 2026-09-09 | -2.56 |
| 2026-09-08 | -2.71 |
| 2026-09-04 | -2.68 |
| 2026-09-03 | -2.76 |
| 2026-09-02 | -2.54 |
| 2026-09-01 | -2.49 |
| 2026-08-31 | -2.53 |
| 2026-08-28 | -2.56 |
| 2026-08-27 | -2.61 |
| 2026-08-26 | -2.62 |
| 2026-08-25 | -2.61 |
| 2026-08-24 | -2.53 |
| 2026-08-21 | -2.57 |
| 2026-08-20 | -2.58 |
| 2026-08-19 | -2.57 |
| 2026-08-18 | -2.47 |
| 2026-08-17 | -2.49 |
| 2026-08-14 | -2.39 |
| 2026-08-13 | -2.79 |
| 2026-08-12 | -2.88 |
| 2026-08-11 | -2.76 |
| 2026-08-10 | -2.79 |
| 2026-08-07 | -2.84 |
| 2026-08-06 | -3.36 |
| 2026-08-05 | -3.33 |
| 2026-08-04 | -3.28 |
| 2026-08-03 | -3.13 |
| 2026-07-31 | -3.19 |
| 2026-07-30 | -3.31 |
| 2026-07-29 | -3.14 |
| 2026-07-28 | -3.11 |
| 2026-07-27 | -3.03 |
| 2026-07-24 | -2.91 |
| 2026-07-23 | -2.99 |
| 2026-07-22 | -3.03 |
| 2026-07-21 | -3.37 |
| 2026-07-20 | -3.37 |
| 2026-07-17 | -3.44 |